FILE PHOTO: Chief Executive of the Russian Direct Investment Fund, Kirill Dmitriev, attends a session of the St. Petersburg International Economic Forum (SPIEF), Russia, June 7, 2019. REUTERS/Maxim Shemetov
MOSCOW (Reuters) - Russia's first potential COVID-19 vaccine will win local regulatory approval in the first half of August and be administered to frontline health workers soon afterwards, a development source close to the matter told Reuters.
A state research facility in Moscow - the Gamaleya Institute - completed early human trials of the adenovirus-based vaccine this month and expects to begin large-scale trials in August.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
